State Medicaid Pharmacy and Therapeutics Commitee Meeting
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Pharmacy and Therapeutics Committee
Notice Information
- Notice Title
- State Medicaid Pharmacy and Therapeutics Commitee Meeting
- Notice Tags
- Medicaid, Pharmacies
- Notice Type(s)
- Meeting
- Event Start Date & Time
- November 18, 2010 07:00 AM
- Event End Date & Time
- November 18, 2010 08:30 AM
- Event Deadline Date & Time
- 11/15/10 06:00 PM
- Description/Agenda
- UTAH DEPARTMENT OF HEALTH STATE MEDICAID PHARMACY AND THERAPEUTICS COMMITTEE Thursday, November 18, 2010 7:00 a.m. to 8:30 a.m. Cannon Health Building Room 114 AGENDA Please note that persons who wish to address the P&T Committee may contact Lisa Hulbert at (lhulbert@utah.gov) at least 7 calendar days prior to the meeting. Comments from visitors, while welcome, may be limited due to time constraints 1. Review and Approval of Minutes. 2. DUR Board up date Robyn Seely, PharmD. Public comment 3. Digestive Enzymes Lisa Hulbert, R.Ph. (Creon, Creon 5, Creon 10, Creon 20, Lipram-PN10, Lipram-PN16, Pancrease MT-4, Pancrease MT-10, Pancrease MT-16, Pancrease MT-20, Pancreaze, Pancrecarb MS-4, Pancrecarb MS-8, Pancrecarb MS-16, Pancrelipase 5,000, Pancrelipase EC, Pangestyme EC, Pangestyme MT 16, Pangestyme UL 20, Panokase, Ultrase, Ultrase MT 12, Ultrase MT 18, Ultrase MT 20, Viokase, Zenpep) Public comment Public comment that responds to the materials presented by the College of Pharmacy @University of Utah is most helpful. The foundation documents used for most reviews are prepared by the Oregon Evidence-based Practice Center or the Drug Information Service and are posted in advance on the P&T Committee website Manufacturers are requested to submit any additional materials they would like reviewed as part of the process to: Dr. Gary Oderda College of Pharmacy, 30 South 2000 East, SLC, UT 84112-5820 All materials must be clearly labeled that they are submitted for consideration as part of the state of Utah Medicaid Preferred Drug List Program review process. Materials must be received at least 60 days before the scheduled review date. Materials most useful to support the evidence-based process include any new evidence (information from clinical trials or studies when possible) after the Oregon monograph was prepared, unpublished materials the company would like considered as part of the process, or any other materials not likely to be included in a literature search. Topics for coming P&T Committee meetings December Acne Preparations January Estrogens for Menopause: estradiol patch, estradiol gel, estradiol oral, estradiol vaginal cream, estradiol vaginal insert, estradiol/norethindrone oral, estradiol/norethindrone patch, estradiol/levonorgestrel transdermal, estradiol/drospirenone oral, esterified estrogen oral, conjugated estrogen oral, conjugated estrogen vaginal cream, conjugated estrogen/medroxyprogesterone oral, estropipate oral, estropipate cream
- Notice of Special Accommodations (ADA)
- Tim Morley, (801) 538-6293
- Notice of Electronic or Telephone Participation
- No
Meeting Information
- Meeting Location
-
288 North 1460 West
Cannon Health Building, Room 114
Salt Lake City, 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Ngan Huynh
- Contact Email
- nganhuynh@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- November 10, 2010 08:06 AM
- Notice Last Edited On
- November 10, 2010 08:06 AM
- Deadline Date
- November 15, 2010 06:00 PM
Subscribe
Subscribe by Email
Subscription options will send you alerts regarding future notices posted by this Body.